Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/05/067217
CTRI/2024/05/067217
Not yet recruiting
Phase 4

A comparative study of the efficacy and safety of olopatadine 0.7% versusalcaftadine 0.25% in allergic conjunctivitis - NI

Pt B.D. Sharma UHS Rohtak0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Pt B.D. Sharma UHS Rohtak
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Pt B.D. Sharma UHS Rohtak

Eligibility Criteria

Inclusion Criteria

  • •Positive medical history of mild to moderate ocular allergies.
  • •\-Best corrected visual acuity of 6 by 12 or better in each eye.
  • •\-Absence of contact lens use for a minimum of three days before and throughout the study period.
  • •\-Willingness to provide informed consent

Exclusion Criteria

  • •\-Diagnosis of persistent dry eye syndrome.
  • •\-Use of any topical eye drops, including ocular lubricants, aside from the investigational drugs within the past seventy two hours, or utilization of any experimental medications or devices within the last thirty days.
  • •\-Taking aspirin, or related products, systemic steroids or H1antihistamines within seven days prior to enrolment.
  • •\-Presence of an active ocular infection.
  • •\-Planned surgical procedures during the study period or recent ocular surgical intervention within three months.
  • •\-Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Comparison between 3 surgical treatments in stable vitiligo patientsHealth Condition 1: L80- Vitiligo
CTRI/2019/11/021900GCS Medical college Hospital and Research center6
Not yet recruiting
Phase 4
To find out effect and safety of luliconazole and ketoconazole in patient with tinea versicolor disease
CTRI/2023/07/055746Pt BD Sharma PGIMS Rohtak
Recruiting
Phase 4
A comparative study of Hemoforce Family as a treatment for iron deficiency anaemia in Ghanaian patients.Haematological DisordersNutritional, Metabolic, EndocrineAnaemia
PACTR202209576526787Shalina Healthcare200
Recruiting
Not Applicable
Efficacy and safety of etomidate sedation in gastric endoscopic submucosal dissectioFactors influencing health status and contact with health services
KCT0007295Korea University Anam Hospital138
Completed
Phase 1
The effect of ajicoat and cadaver on burn treatment
IRCT20190807044468N1Esfahan University of Medical Sciences50